Limited utility of early trough cyclosporine level monitoring to predict the rate of acute rejection in the first three months after cardiac transplantation.
Jennison
S H
SH
Heart Failure/Heart Transplant Program, St Louis University Health Sciences Center, Missouri 63110-0250.
Wesp
A G
AG
McBride
L R
LR
Miller
L W
LW
D000208:Acute Disease; D000704:Analysis of Variance; D001707:Biopsy, Needle; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000097:blood* / Q000627:therapeutic use; D016903:Drug Monitoring; D005260:Female; D006084:Graft Rejection / Q000175:diagnosis / Q000453:epidemiology* / Q000517:prevention & control; D016027:Heart Transplantation / Q000276:immunology* / Q000401:mortality / Q000473:pathology; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D012189:Retrospective Studies; D015996:Survival Rate; D013997:Time Factors; D014184:Transplantation, Homologous
D016572:Cyclosporine; D003404:Creatinine; D008775:Methylprednisolone